Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
Helus Pharma Announces Chief Executive Officer Transition; Eric So to Resume Role as Interim Chief Executive Officer
-
Ionic Digital Announces March 2026 Mining and Operations Update
-
Trinity Capital Inc. Provides $50 Million in Growth Capital to Cala Health to Support Commercial Expansion of Wearable Tremor Therapy
-
Fulcrum Therapeutics to Host First Quarter 2026 Financial Results Conference Call and Webcast on Monday, April 27, 2026, at 8:00 a.m. ET
-
Sapience Therapeutics Presents First Clinical Results from Phase 2 Study of ST316, First-in-Class β-catenin Antagonist, in Second-Line Colorectal Cancer at the American Association for Cancer Researc
-
Axe Compute Unveils Compute Reserve Dashboard, Giving Investors a Unified View of Its NASDAQ Stock and Operational Strategic Compute Reserve
-
Group Coaching Weekly Launches Live Program Focused on Structured Thinking and Real-Time Growth
-
Steven Rivera Appointed Chief Revenue Officer of NRI North America
-
Notable Capital Launches Inaugural Prosumer AI 40
-
Dent Repair Shop Experience Explained in HelloNation Featuring Dent Repair Expert Leo Plourde
-
Escoffier Scholarship Foundation Advances Toward $1 Million Milestone at Spring Fundraising Event
-
Deck Bio Presents Preclinical Data on DBXO-1, a Multi-pMHC Targeted T Cell Engager, at AACR 2026
-
BioCardia and Japan PMDA Align on Acceptability of CardiAMP Clinical Data to Support Regulatory Approval in Ischemic Heart Failure
-
Arevon Earns Gold Certification for Diversity, Equity, Inclusion, and Justice Initiatives from the Solar Energy Industries Association
-
Pioneer Celebrates a Century of Innovation, Delivering for Farmers
-
LENZ Therapeutics Announces Submission of Marketing Authorization Application to the Medicines and Healthcare products Regulatory Agency for VIZZ® for the Treatment of Presbyopia in the United Kingdo
-
Leading School Safety Platform Enables Schools To Provide Parents Visibility Into Their Children's AI Usage
-
Callan JMB Launches The Atlas Complex in Alabama to Successfully Achieve the Capture of Significant Pharmaceutical Onshoring Demand and Expand U.S. Supply Chain Infrastructure
-
HEART RHYTHM 2026: THE WORLD'S LEADING EP EVENT RETURNS FOR ITS 47TH YEAR, UNVEILING CUTTING-EDGE SCIENCE SHAPING THE FUTURE OF ARRHYTHMIA CARE
-
MaxsMaking Inc. Commences U.S. Business Operations
-
Ascendis Pharma Announces Commencement of Trading of its Ordinary Shares on Nasdaq
-
Jersey Mike's Announces Confidential Submission of Draft Registration Statement for Proposed Initial Public Offering
-
AskBio's Viralgen to Supply Commercial-Scale Drug Product for REGENERATE-PD Investigational Gene Therapy Phase II Trial for Parkinson’s Disease
-
Airsys Introduces Next-Generation LiquidRack™ Technology to Provide a Simpler Liquid Cooling Architecture for Retrofit, Edge, and Mid-Density AI Infrastructure
-
Having more kids associated with reduced risk of stroke and brain damage, research co-led by UT Health San Antonio shows
-
Acurx Pharmaceuticals to Discuss First Quarter 2026 Financial Results on May 12, 2026 Conference Call and Provide Business Update
-
Ampersand Biomedicines Presents Preclinical Data on AMP-220, a Gut-Targeted IL-22 AND-Body™ Therapeutic, at AAI 2026
-
Astec Names Chad Hartley Group President – Infrastructure Solutions
-
Cloudbound™ Expands to Dallas, Bringing Its Early Childhood "World of Play" to Frisco
-
Farmers & Merchants Bank of Long Beach Reports 2026 First Quarter Results
-
Maxell Establishes Corporate Byline “Micro batteries. Maximum impact.”
-
Source Support Services Unveils the Unified Services Platform
-
Claritev Corporation Announces First Quarter 2026 Earnings Conference Call
-
NFTYDoor Becomes Independent Company and Expands Home Equity Credit Box
-
Rayonier Advanced Materials Announces Comprehensive Strategic Alternatives Review to Maximize Shareholder Value
-
McKesson Signs Agreement with Apollo Funds for Strategic Minority Interest in Medical-Surgical Solutions
-
Atsena Therapeutics Receives Data Monitoring Committee Recommendation to Proceed with Pivotal Part C Cohort of Phase 1/2/3 LIGHTHOUSE Trial Evaluating ATSN-201 in Patients with X-linked Retinoschisis
-
Surf Air Mobility Announces $15 Million Registered Direct Offering of Common Stock And New $15 Million Asset-Backed Loan
-
Samsung Bioepis Presents Nonclinical Data for its First Novel Antibody-Drug Conjugate Candidate SBE303 at AACR 2026
-
Abacus Global Management to Participate in the 2026 Milken Institute Global Conference
-
CenterWell Introduces the Fulfillment Index, a New Measure of What It Means to Age Well
-
Monster Energy's Jasmine Jasudavicius Defeats Karine Silva at UFC Fight Night 273
-
Saildrone Unveils Spectre, a New Class of High-Speed Unmanned Surface Vessel for Naval Operations
-
Mercury GSE Announces Eric Davis as Vice President of Operations
-
Smartflyer and H55 Advance Electric Aviation with First Delivery of Certifiable Battery Modules for the SFX1 Aircraft
-
Treasure Data® Becomes Treasure AI™, Delivering 10x Value to Marketers in 10 Minutes with Its Agentic Experience Platform
-
Global Uranium Completes Phase 1 Earn-In at Astro Project and Secures Initial 20% Interest
-
Hadron Energy Aligns Valuation for Business Combination to $600M, Signaling Long-Term Market Discipline After GigCapital7 Form S-4 Registration Statement Declared Effective
-
Fairbanks Morse Defense’s All-Electric Davit by Welin Lambie Achieves First Article Test Milestone for US Coast Guard Offshore Patrol Cutter Program
-
Bow River Capital Expands Private Equity Team with Addition of Amanda Tallman as Head of Business Development
